Laura Revolinsky v. Bayer Corporation

CourtCourt of Appeals for the Seventh Circuit
DecidedJune 10, 2026
Docket25-2401
StatusPublished
AuthorHamilton

This text of Laura Revolinsky v. Bayer Corporation (Laura Revolinsky v. Bayer Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Laura Revolinsky v. Bayer Corporation, (7th Cir. 2026).

Opinion

In the

United States Court of Appeals For the Seventh Circuit ____________________ No. 25-2401 IN RE: SERESTO FLEA AND TICK COLLAR MARKETING, SALES PRACTICES, AND PRODUCTS LIABILITY LITIGATION v.

APPEAL OF: LAURA REVOLINSKY, Plaintiff-Appellant. ____________________

Appeal from the United States District Court for the Northern District of Illinois, Eastern Division. No. 1:21-cv-04447 — John Robert Blakey, Judge. ____________________

ARGUED FEBRUARY 13, 2026 — DECIDED JUNE 10, 2026 ____________________

Before BRENNAN, Chief Judge, and HAMILTON and SCUDDER, Circuit Judges. HAMILTON, Circuit Judge. We affirm denial of appellant Laura Revolinsky’s motion challenging the allocation of fees among plaintiffs’ attorneys in the settlement of a multidistrict litigation. To the extent the district court’s orders might be understood as having delegated final authority to lead 2 No. 25-2401

plaintiffs’ counsel to distribute the total fee award among many attorneys and firms, we would have serious misgivings. The district court did not abuse its discretion, however, by enforcing its prior orders establishing procedures and requirements for seeking attorney fees and expenses. I. Factual and Procedural Background This attorney fee appeal arises from multidistrict litigation over marketing, sales practices, and products liability regarding Seresto flea and tick collars, medical devices that allegedly injured or killed thousands of pets. Plaintiffs across the country brought class-action lawsuits against defendants Bayer Corporation, related Bayer entities, and Elanco Animal Health, Inc., which purchased Bayer’s animal health division, including the Seresto product lines, in 2020. One such case was filed in the District of New Jersey by plaintiff-appellant Laura Revolinsky through her attorneys, Joseph LoPiccolo of Poulos LoPiccolo PC and Bruce Nagel of Nagel Rice, LLP. The complaint sought relief for a putative class of pet owners to be represented by Revolinsky. Attorneys Nagel and LoPiccolo filed and briefed a motion asking the Judicial Panel on Multidistrict Litigation to assign Revolinsky’s case and other similar cases in other districts to the District of New Jersey for coordinated pretrial proceedings under 28 U.S.C. § 1407. Attorney Rachel Soffin filed another brief on behalf of several other plaintiffs, also supporting MDL treatment but seeking transfer to the Western District of Missouri instead. Soffin and Randee Matloff, another Nagel Rice attorney representing Revolinsky, both appeared at the panel hearing to argue for MDL treatment and in support of their preferred transfer destinations. The panel approved MDL treatment but No. 25-2401 3

transferred these and other parallel cases to the Northern District of Illinois, as defendants had proposed. After transfer, the district court granted a motion supported by twelve of the now sixteen sets of plaintiffs to appoint Soffin and attorneys Michael Reese and Michael Williams as Class Counsel. The court also appointed attorney Carl Malmstrom to serve as Liaison Counsel between Class Counsel and the other plaintiffs’ attorneys. Revolinsky had sought the appointment of two Nagel Rice attorneys as interim lead counsel, but the court denied that proposal. At the time of the MDL transfer, most of the cases were still in their early stages. None had yet proceeded to formal discovery, including Revolinsky’s. The district court asked the parties to submit a proposed case management order. At a status conference, Reese said that in his experience with another MDL proceeding in the Northern District of Illinois, establishing a time and expense protocol at the start of the litigation would promote efficient collaboration among plaintiffs’ counsel. The district court entered Case Management Order No. 4: Plaintiffs’ Counsel Time and Expense Protocol. Order No. 4 required every plaintiffs’ attorney to obtain Class Counsel’s written approval before engaging in compensable work or incurring expenses. The court also limited compensation as follows: “Generally, only time and expense incurred after the Court’s February 7, 2022 Order appointing Plaintiffs’ Leadership shall be submitted and considered as potential Common Benefit Work.” See In re Cendant Corp. Securities Litig., 404 F.3d 173, 191 (3d Cir. 2005) (noting importance of ensuring that non-lead attorneys’ compensable work actually benefits class without duplicating work of lead counsel). In a 4 No. 25-2401

footnote, the district court added here: “In their discretion, [Class] Counsel may consider time and expense incurred before the Court’s February 7, 2022 Order as Common Benefit Work and Common Benefit Expense if the time or expense benefitted the proposed class members in a material and direct way.” Order No. 4 required attorneys to submit monthly time and expense reports to Class Counsel and warned that failure to make timely submissions would be grounds for denying recovery. It also said that Class Counsel “will be responsible for collecting and reviewing monthly common benefit time and expense submissions from MDL Counsel and informing MDL Counsel when their submissions do not comply with the directives set forth in this Order.” Revolinsky’s attorneys did not object to Order No. 4 or propose any alternative time and expense management order. Revolinsky’s attorneys received notice of Order No. 4 via the electronic case filing system and by email. Reese’s email to Nagel Rice, which the firm forwarded to LoPiccolo, referred to the “CMO entered by the Court” and advised: “For this first time and expense report, you should include all time from inception to date through March 31, 2022.” Apparently, LoPiccolo did not seek clarification regarding the order to which Reese referred or what Reese meant by “inception.” Instead, both the Nagel Rice and Poulos LoPiccolo firms submitted their first time and expense reports on time. The majority of time and expenses sought was for pre-transfer work on the motion before the JPML. Class Counsel did not respond to these submissions to inform the firms that pre- appointment time would not be compensated. No. 25-2401 5

Nagel Rice timely submitted all subsequent reports. Poulos LoPiccolo, on the other hand, did not submit another report until June 2023. Attorney LoPiccolo incorrectly assumed that Class Counsel would request submissions as necessary. When LoPiccolo asked to submit belatedly his firm’s time and expenses for August 2022 to April 2023, Liaison Counsel Malmstrom responded: “If you want to send on your hours to myself, [my paralegal] and the three co- leads, they can make a determination as to what hours are eligible for submission to the Court.” (Alteration in original). LoPiccolo submitted the report but apparently did not follow up with Malmstrom or Class Counsel. In December 2023, after negotiations conducted by Class Counsel, the parties reached a nationwide settlement agreement to establish a $15 million fund to compensate plaintiffs and to pay attorney fees and litigation costs. The proposed agreement capped the combined recoverable fees for all plaintiffs’ attorneys at 38% of the settlement fund. In January 2024, the court granted preliminary approval of the proposed settlement, set the deadline for the attorney fee application as June 17, 2024, and set the deadline for opt-outs and objections to the settlement and to the fee application as July 22, 2024. Class Counsel requested just over $4.5 million in fees, calculated based on a lodestar of 6101 hours across all firms, for a mean rate of around $750 per hour. They also sought just over $150,000 in litigation expenses. Neither the motion, the accompanying memorandum of law, nor the supporting declaration set forth the specific fee amount allocated to each firm.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bowles v. Russell
551 U.S. 205 (Supreme Court, 2007)
In the Matter Of: Synthroid Marketing Litigation
325 F.3d 974 (Seventh Circuit, 2003)
In Re High Sulfur Content Gasoline Products Liab.
517 F.3d 220 (Fifth Circuit, 2008)
Spicer v. Chicago Board Options Exchange, Inc.
844 F. Supp. 1226 (N.D. Illinois, 1993)
Allapattah Services, Inc. v. Exxon Corp.
454 F. Supp. 2d 1185 (S.D. Florida, 2006)
Kent Eubank v. Pella Corporation
753 F.3d 718 (Seventh Circuit, 2014)
Sulejman Nicaj v. Shoe Carnival Incorporated
768 F.3d 622 (Seventh Circuit, 2014)
Plaintiffs' Lead Counsel v. Life Time Fitness, Inc.
847 F.3d 619 (Eighth Circuit, 2017)
Theodore Frank v. Target Corporation
968 F.3d 827 (Seventh Circuit, 2020)
In re: Syngenta AG MIR162
61 F.4th 1126 (Tenth Circuit, 2023)
Timothy Upchurch v. Timothy O'Brien
111 F.4th 805 (Seventh Circuit, 2024)

Cite This Page — Counsel Stack

Bluebook (online)
Laura Revolinsky v. Bayer Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/laura-revolinsky-v-bayer-corporation-ca7-2026.